# Low-dose Rituximab Regimens in Chinese Adult Patients With Immune Thrombocytopenia

> **NCT01719692** · NA · COMPLETED · sponsor: **Institute of Hematology & Blood Diseases Hospital, China** · enrollment: 100 (actual)

## Conditions studied

- Immune Thrombocytopenic Purpura

## Interventions

- **DRUG:** Rituximab

## Key facts

- **NCT ID:** NCT01719692
- **Lead sponsor:** Institute of Hematology & Blood Diseases Hospital, China
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-10
- **Primary completion:** 2015-10
- **Final completion:** 2016-02
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2026-02-11

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01719692

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01719692, "Low-dose Rituximab Regimens in Chinese Adult Patients With Immune Thrombocytopenia". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT01719692. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*